California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

During the quarter, broad U.S. equity markets rose amid moderating inflation, strong corporate earnings growth and weakening ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

The "Global Neurology Devices Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Product Type, Treatment Stage, End-Users, Region, By Country: 2020-2030" report has been added to ...

The Federal Court of Australia has ordered Medtronic Australasia Pty Ltd (Medtronic) to pay $22 million in penalties for ...

Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

Medtronic plans to use data from the ADAPT-PD trial to support ... Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The market’s optimism surrounding the firm is also visible in its valuation as Boston Scientific Corporation (NYSE:BSX) ...